Industry News

The latest medical device regulatory news, clinical trials, and market insights

Home / News
2,227 articles
Europe

First Swissmedic Authorisation for KIMMTRAK®: A Key Milestone in Oncology Therapy

Swissmedic has released a pivotal regulatory announcement regarding the authorisation of KIMMTRAK®, marking its first approval for clinical use. This…

November 7, 2025 Dr. Hatem Rabeh
Europe

Swissmedic Announces Extension of Indication for Retsevmo®: Regulatory Update

On November 7, 2025, Swissmedic officially announced the extension of the therapeutic indication for Retsevmo®, a key development for clinical,…

November 7, 2025 Dr. Hatem Rabeh
Latest News

FDA Cracks Down on Illegal Marketing of Unapproved Botulinum Toxin Products

The U.S. Food and Drug Administration (FDA) has issued formal warnings to 18 website owners found marketing unapproved and misbranded…

November 7, 2025 Dr. Hatem Rabeh
Latest News

FDA Expands National Priority Voucher Program With Six New Awardees

The U.S. Food and Drug Administration (FDA) has announced six additional recipients of the Commissioner’s National Priority Voucher (CNPV) pilot…

November 7, 2025 Dr. Hatem Rabeh
Europe

Swissmedic Annual Report: GCP Inspections in Clinical Trials Highlight Key Compliance Areas

Swissmedic has released its annual report detailing the results of clinical trial inspections conducted as part of Good Clinical Practice…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

New Clinical Trial for Glioblastoma Highlights Adjuvant Temozolomide and Sonodynamic Therapy Innovations

A novel clinical trial aims to investigate a groundbreaking combination therapy for newly diagnosed glioblastoma patients. Sponsored by Alpheus Medical,…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

Upcoming Clinical Trial to Explore OptiCreatine’s Impact on Creatine Absorption and Digestive Health

A new clinical trial is set to investigate the effects of OptiCreatine on plasma creatine levels and digestive health in…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

Upcoming Clinical Trial: Exploring Low Intensity Focused Ultrasound for Autism Therapy

The Medical University of South Carolina, in collaboration with the National Institute of General Medical Sciences (NIGMS) and the COBRE…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

Clinical Investigation to Assess Ketone Safety Thresholds with Dapagliflozin in Type 1 Diabetes Management

The global healthcare community continues to explore innovative ways to manage Type 1 Diabetes Mellitus (T1DM). A new clinical investigation,…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

New Clinical Trial Explores Topical Poly-L-lactic Acid with Microneedling for Perioral Wrinkles

A novel clinical trial aims to study the combined effect of Poly-L-lactic Acid (PLLA) and microneedling for treating perioral wrinkles.…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

Rhodiola Rosea Trial Results: Unlocking Cognitive Enhancement and Anaerobic Performance

The clinical trial titled “Short-Term Rhodiola Rosea for Anaerobic Performance and Cognitive Function in Resistance-Trained Adults” conducted by Jacksonville State…

November 6, 2025 Dr. Hatem Rabeh
Clinical Trials

Liquid IV’s Pre-Workout Clinical Trial: Examining Strength, Endurance, and Cognitive Performance

Clinical teams and regulatory professionals are closely watching the development of Liquid IV’s proprietary pre-workout dietary supplement. A new clinical…

November 6, 2025 Dr. Hatem Rabeh
Loading more articles...
Scroll to Top